chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left arm hurting for a day or so after the previous shots; probably the 1st hurt more than the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (left arm hurting for a day or so after the previous shots; probably the 1st hurt more than the 2nd dose) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 010M20A or 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (left arm hurting for a day or so after the previous shots; probably the 1st hurt more than the 2nd dose). At the time of the report, VACCINATION SITE PAIN (left arm hurting for a day or so after the previous shots; probably the 1st hurt more than the 2nd dose) outcome was unknown.      No Concomitant medication was reported.     No treatment medications were reported.   This case was linked to MOD-2021-405941 (Patient Link).
Approximately 10-15 minutes following vaccination, I nearly fainted. My vision blurred and I felt I was loosing consciousness. My ears were ringing and I had a difficult time hearing noise. Thankfully, by the grace of God, I did not faint and recovered from this part of my adverse effect.   I would say that the next 1-2 days were "normal" in terms of my vaccine reaction. Like others, I was tired and sore.  However, the soreness in my left arm, where the vaccine was given, has not gone away 3.5 months later. I am still quite sore and it does sometimes affect my ability to function. My heart has also been in minor pain and has been aching.  I have considered seeing a medical professional, but have decided against it due to the cost. However, I have firmly decided against getting future doses of the COVID-19 vaccine due to how the first dose affected me.
Pfizer 2/23/21, 3/16/21. Positive on 12/6/22
Chest pain, sever abdominal pain, headache , dizziness, pain in legs, diarrhea
Information has been received from a nurse concerning a pt who on 15Sep05 was vaccinated with pneumococcal 23v polysaccharide vaccine (0.5ml) (lot 649981/0704P or 650451/0750P), IM. Subsequently, on 16Sep05, the pt called the office complaining of local reaction described as large swollen, reddened, hot area in left arm from deltoid down to elbow. Unspecified medical attention was sought. No product quality complaint involved. Additional information has been requested.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The pertinent medical history and concomitant medication was not reported. On 01-JUL-2015, the patient was vaccinated with unspecified number of improperly stored doses of M-M-R II (lot: K004949 and Expiry: 04-APR-2016) (route unspecified). No adverse effect was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Extreme testicle pain, along with extreme skin skin, muscle, and bone sensitivity and pain.; Extreme testicle pain, along with extreme skin skin, muscle, and bone sensitivity and pain.; Extreme testicle pain, along with extreme skin skin, muscle, and bone sensitivity and pain.; Extreme testicle pain, along with extreme skin skin, muscle, and bone sensitivity and pain.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Jun2021 17:00 (Batch/Lot number: unknown) at the age of 26 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN D NOS. Vaccination history included: Bnt162b2 (DOSE 1, SINGLELot number: UNKNOWNAnatomical site: Left armAdministration time: 17:00), administration date: 22May2021, when the patient was 26 years old, for COVID-19 immunisation. The following information was reported: TESTICULAR PAIN (non-serious), PAIN OF SKIN (non-serious), MYALGIA (non-serious), BONE PAIN (non-serious) all with onset 13Jun2021 12:00, outcome "recovering" and all described as "Extreme testicle pain, along with extreme skin skin, muscle, and bone sensitivity and pain.". Therapeutic measures were not taken as a result of testicular pain, pain of skin, myalgia, bone pain. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax c/o cellulitis next day adm to ER for observation &Oxacillin to cover routine skin pathogens;resolved;
Monovalent COVID 19  Booster Vaccine was administered incorrectly, since the agency removed the authorization.
Fainted after vaccination given. Fell from chair to the floor after Hepatitis A vaccine in (L) deltoid and HPV GARDASIL 9 in (R)r deltoid. IM - immediately fainted after 2nd vaccine. No injury.
Localized redness, warmth, swelling of LUE, with mild swelling, decreased strength, and numbness of left upper extremity. Associated with mild left sided neck pain, flushed left cheek, and headache.  Treatment: cool compress every 2 hours, BENADRYL every 6 hours-if not improvement in one day, prednisone x 3 days. Symptoms were already improving.
Treatment of COVID-19; Treatment of COVID-19; vaccine brand other=Moderna,; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 06Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 27Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 17Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 02May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 62 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 08Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 08Sep2022, outcome "unknown", described as "vaccine brand other=Moderna,"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15Oct2023, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: Covid-19 Treatment; (15Oct2023) positive, notes: I experienced fever and tested positive for COVID 15Oct2023. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: She experienced fever and tested positive for COVID 15Oct2023. Only other symptom was mild nasal stuffiness. Started Paxlovid that night, took the 5-day course. Patient had no known allergies.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300351207  same patient, different drug/AE;
fever x 1 day; an area of erythema, sl induration, mild tenderness surrounding the inject site of approx 3 cm
Went to bed with elevated temp on 4/3/3021 around 2100 and awakened 0700 04/04/2021 experiencing extreme stiffness in muscles of legs and arms with bilateral tremor on intent in both hands. Thumbs were stiff, precluding writing or holding a pen.  I called my physician to let her know what was happening and, thinking it may have been a drug induced dyskinesia, stopped B6 and tapered off Effexor as they both could worsen this. I started taking diphenhydramine 25 mg q8 h and continued for approximately two weeks when symptoms began to subside . I have since seen my physician who will continue to monitor and have started back the Effexor and B6.
dizziness, nausea; took antivert without noticeable effect, recovered in 12 hrs
Absence of menstruation following booster vaccine.  Pregnancy symptoms: Swollen, vascularized breast tissues,  colostrum from nipples, bloating, headache, nausea (intermittent) fatigue during time period should have begun.  No bleeding and period is over 11 days late.
1/13/03- Employee noticed soreness deep in the muscle below the injection site on the right deltoid whenever she was working out with weights. It still aches when she lifts her right arm to shoulder heighth and moves it up and backward. It hurts to push on the site, also. No achiness when she moves arm forward. No limitation in the range of motion. No fever; no redness or discoloration at site; no malformation of muscle.  Emp. just concerned if achiness will ever go away. No treatment sought as yet. Continues to work out with weights.
Patient developed redness and rash on left arm at injection site the day after the vaccine (11/15). Then on 11/16 the rash started at both feet and continued to spread up the legs. Patient came into office for an urgent care visit 10 days after injection (11/24). The rash had reached up to the groin area. Patient stated that it did not itch or burn. He got the vaccine 14 days after being positive for COVID, but had no symptoms.
Elevated heart rate; Brain fog; Dehydrated; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo), DEHYDRATION (Dehydrated), FEELING ABNORMAL (Brain fog) and HEART RATE INCREASED (Elevated heart rate) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Hashimoto's thyroiditis in September 2000, Upset stomach, Insomnia and Rash. Concurrent medical conditions included Drug allergy (Sensation to all medicine). Concomitant products included LEVOTHYROXINE SODIUM (TIROSINT) for Hashimoto's thyroiditis.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021 at 7:30 AM, the patient experienced VERTIGO (Vertigo). On 17-Mar-2021 at 3:00 AM, the patient experienced DEHYDRATION (Dehydrated). On 22-Mar-2021, the patient experienced FEELING ABNORMAL (Brain fog). On 28-Mar-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate). At the time of the report, VERTIGO (Vertigo), DEHYDRATION (Dehydrated), FEELING ABNORMAL (Brain fog) and HEART RATE INCREASED (Elevated heart rate) had not resolved. Not Provided          No treatment was provided.
Trouble breathing  Narrative:  Patient presented to the ED 2 days after first dose of COVID vaccine  with a pruritic rash as well as trouble breathing. He reported the rash which was  urticarial and quite pruritic was generalized, ranging from his face over his neck  and back. Initially he had little relief from diphenhydramine, but after a second  dose the rash was largerly resolved. Patient denied chest tightness, wheezing,  tongue or lip swelling. He did not report any GI symptoms, fevers, mild myalgias  but only with a slight headache. No loss of taste or spelled sensation. The rash  most prominent on the right forehead raised a suspicion of herpes zoster which  could also cause a headache, but ED provider ruled this out because patient had  received his herpes zoster vaccination. The rash was also not painful although  bilateral and asymmetric. ED physician concluded it to be a mild reaction to the  vaccine. Patient was discharged on H1 and H2 blockers (diphenhydramine and  famotidine)
fever; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 19Oct2021 09:15 (Batch/Lot number: unknown) at the age of 63 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: LOSARTIN. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion, Location of injection: Arm Right, Vaccine Administration Time: 09:30 AM, Route of Administration: Intramuscular), administration date: 30Sep2021, when the patient was 63 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 19Oct2021 14:45, outcome "not recovered", described as "fever"; NAUSEA (non-serious) with onset 19Oct2021 14:45, outcome "not recovered", described as "Nausea". Therapeutic measures were not taken as a result of pyrexia, nausea.  Additional information: No known allergies. Facility type vaccine was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Losartin 100 mg medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19. Adverse event resulted in none of the above.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further  information is expected.
Pt given Hepatitis A #2 & Hepatitis B #3 in arm immediately after c/o not feeling well, ashen color unconscious w/o closing eyes, did not respond to voices lasted a few seconds responded for a few minutes then lapsed into unconsciousness again became rigid & incontinent. 911 called. Pulse assessed - 50, BP 90/50, diaphoretic. EMT's arrived assessed pt now conscious and responding BP 90/50, pulse ox 96, pulse 74 - BS 141 - alert & oriented x 4 - did not go to ER. Followed up with Primary Care Physician.
Patient was seen at the local ER for c/o abdominal pain, fever, nausea, generalized body aches, SOB, lethargy and confusion.  Dx of Covid Pneumonia.  Patient was stable throughout admission and was discharged home on 7-29-23 to follow up with primary physician within 7-10 days.
With the 1st dose, general fatigue/malaise, pain to whole arm of injection and into neck. Low grade fever.  With 2nd dose, inability to lift injected arm higher than 25 degrees or turn neck for 24-48 hours with pain in both sites, fever, fatigue/malaise. Total body chills and aches.
Brother in law is dying; This spontaneous case was reported by a patient family member or friend and describes the occurrence of IMMUNISATION REACTION (Brother in law is dying) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Brother in law is dying) (seriousness criterion medically significant). At the time of the report, IMMUNISATION REACTION (Brother in law is dying) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.  Company comment. This spontaneous case concerns a male patient (unknown age) with no medical history reported, who received a dose of mRNA  1273 vaccine and experienced the unexpected, serious medically significant event of immunisation reaction. Vaccination date and onset date of the event were not reported; hence latency and temporal association cannot be properly assessed. The report mentioned the patient "is dying". No further clinical details were provided for medical reviewing. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2022-639230, US-MODERNATX, INC.-MOD-2022-639297 (E2B Linked Report).; Sender's Comments: This spontaneous case concerns a male patient (unknown age) with no medical history reported, who received a dose of mRNA  1273 vaccine and experienced the unexpected, serious medically significant event of immunisation reaction. Vaccination date and onset date of the event were not reported; hence latency and temporal association cannot be properly assessed. The report mentioned the patient "is dying". No further clinical details were provided for medical reviewing. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. US-MODERNATX, INC.-MOD-2022-639230:Mother case US-MODERNATX, INC.-MOD-2022-639297:Father-in law case
After administration of GARDASIL in left arm, patient experiences numbness and tingling extending from neck down entire arm. Arm felt weak, difficult to lift. She described a "lump" in her throat. BENDARYL and ibuprofen were administered.
same day as vaccine had 2 episodes of irritability, screaming during which time couldn't be consoled, fretfulness lasting 20min;
Information has been received from a health professional (pharmacy student) concerning a female (age unknown) who on approximately 13-JUL-2007 was vaccinated with a dose of Zostavax (Oka/Merck).  On approximately 13-JUL-2007, the patient developed painful rash below breast and persisted.  The pharmacy student stated that this may be shingles because the patient was asking about reactivation of shingles after receiving Zostavax (Oka/Merck).  Additional information has been requested.
having left arm pain; cant move her left arm; arm barely able to function; Upset; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 2M3K) for prophylaxis.   On 27-JUL-2023, the patient received the 2nd dose of Shingrix (intramuscular, left deltoid). On 27-JUL-2023, less than a day after receiving Shingrix, the patient experienced pain in arm (Verbatim: having left arm pain), injected limb mobility decreased (Verbatim: cant move her left arm), activities of daily living impaired (Verbatim: arm barely able to function) and emotional distress (Verbatim: Upset). The outcome of the pain in arm, injected limb mobility decreased and activities of daily living impaired were not resolved and the outcome of the emotional distress was not reported.   It was unknown if the reporter considered the pain in arm, injected limb mobility decreased, activities of daily living impaired and emotional distress to be related to Shingrix.     It was unknown if the company considered the pain in arm, injected limb mobility decreased, activities of daily living impaired and emotional distress to be related to Shingrix.   Additional Information: GSK receipt date: 31-Jul-2023 The patient stated that she had a dose of Shingrix vaccine and was upset stating she was having left arm pain, could not move her left arm and just barely able to function.  The patient stated these details started the day of receiving her Shingrix vaccine.  The patient did not specify whether or not these events had resolved.  The patient questioned that what can be done to help her and repeatedly asked how she could help her so, gave medical disclaimer.  Referred to health care professional and spoken as per package insert and content.  Provided medical information phone number for health care professional reference.  Offered after call survey.  The reporter consented to follow up.
Symptomatic 4/22 really bad muscle pains and aches in her back. She was having sore throat, diarrhea, and abdominal pains. She also lost her taste and smell.
pt was on her way to her car when noticed she had rash on the right neck and c/o of numbness to right side of tough. came back in, benadryl was  given.  after 15 mins she was feeling well,walked out.
First 48 hrs.: fatigue, body aches, and raspy cough with a hard, red, circular swelling  at the injection site that was very painful if touched.   After that subsided, a red, contact-dermatitis-type rash began as a small spot on my forehead, then spread to include a number pf patches on my forehead, upper cheeks (especially along the rims of my glasses) and  neck, with random single hives on my left forearm, right side, and 4th right toe, as well as a scratchy airway and "allergic" cough.  It looks and feels like poison ivy (to which I am very allergic), but >I have not been outdoors or in contact with anything unusual< (and certainly my face has not) - and as an initial precaution, when the first patch appeared, I scrubbed down thoroughly with tecnu and rinsed, followed by mild dish detergent & water, followed by water, followed by Caladryl  (I am an old hand at this).   This would normally shut  down my allergic response even to direct contact with urushiol (e.g., from poison ivy while gardening).   In this case, no.
his wife was hospitalized due to kidney infection; This is a spontaneous report via a Pfizer-sponsored program. A contactable consumer reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1, via an unspecified route of administration on 09Mar2021 (Batch/Lot number was not reported) at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported. It was stated that they missed their 2nd shot of vaccine on 30Mar2021 along with his wife. However, his wife was hospitalized due to kidney infection (Mar2021) from March 24th to 26Mar2021 and they were in the hospital the whole week. The reporter mentioned that his wife was already out of the hospital and he is trying to figure out where to get their 2nd shot of covid vaccine since they've missed it. The outcome of the event was unknown.   Information about lot and batch number was requested.
Redness and swelling where DTAP was given. Pt given hydroxyzine syrup.